MTOR and neoplasm: Furthermore, sorafenib blocked tumorigenesis of HCCLM3 cells more effectively than that of HCCLM3/mTOR cells, manifesting as reduced tumor volumes and tumor weights, with minimal effects on body weights of nude mice (Fig. 1I–L).